価格表

在庫・価格 : 2024年05月08日 07時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Visfatin, C-terminal, Human, EIA Kit, Extraction Free (96well)
データシート※最新のデータシートでない場合があります
EK-003-80 PPEフェニックス ファーマシューティカルス
Phoenix Pharmaceuticals, Inc.
1 kit ¥167,000
(未発注)
追加

在庫・価格 : 2024年05月08日 07時43分 現在

Visfatin, C-terminal, Human, EIA Kit, Extraction Free (96well)

  • 商品コード:EK-003-80
  • メーカー:PPE
  • 包装:1kit
  • 価格: ¥167,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Chan DC et al. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin. Chem. 2005 Mar;51(3):578-85
Chan DC et al
2005/01/01
PubMed
2 Berndt J et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005 Oct;54(10):2911-6
Berndt J et al
2005/01/01
PubMed
3 Chen MP et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2006 Jan;91(1):295-9
Chen MP et al
2006/01/01
PubMed
4 Hammarstedt A et al. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J. Clin. Endocrinol. Metab. 2006 Mar;91(3):1181-4
Hammarstedt A et al
2006/01/01
PubMed
5 Otero M et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2006 Sep;65(9):1198-201
Otero M et al
2006/01/01
PubMed
6 Haider DG et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J. Clin. Endocrinol. Metab. 2006 Apr;91(4):1578-81
Haider DG et al
2006/01/01
PubMed
7 Krzyzanowska K et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin. Sci. 2006 May;110(5):605-9
Krzyzanowska K et al
2006/01/01
PubMed
8 Curat CA et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006 Apr;49(4):744-7
Curat CA et al
2006/01/01
PubMed
9 B旦ttcher Y et al. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J. Clin. Endocrinol. Metab. 2006 Jul;91(7):2725-31
B旦ttcher Y et al
2006/01/01
PubMed
10 Pagano C et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J. Clin. Endocrinol. Metab. 2006 Aug;91(8):3165-70
Pagano C et al
2006/01/01
PubMed
11 Haider DG et al. Free fatty acids normalize a rosiglitazone-induced visfatin release. Am. J. Physiol. Endocrinol. Metab. 2006 Nov;291(5):E885-90
Haider DG et al
2006/01/01
PubMed
12 Haider DG et al. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006 Aug;49(8):1909-14
Haider DG et al
2006/01/01
PubMed
13 Nowell MA et al. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 2006 Jul;54(7):2084-95
Nowell MA et al
2006/01/01
PubMed
14 Frydelund-Larsen L et al. Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise. Am. J. Physiol. Endocrinol. Metab. 2007 Jan;292(1):E24-31
Frydelund-Larsen L et al
2007/01/01
PubMed
15 Haider DG et al. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4702-4
Haider DG et al
2006/01/01
PubMed
16 Schindler K et al. Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects. Eur. J. Clin. Invest. 2006 Sep;36(9):640-6
Schindler K et al
2006/01/01
PubMed
17 Jian WX et al. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabet. Med. 2006 Sep;23(9):967-73
Jian WX et al
2006/01/01
PubMed
18 Dogru T et al. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res. Clin. Pract. 2007 Apr;76(1):24-9
Dogru T et al
2007/01/01
PubMed
19 Tan BK et al. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. J. Clin. Endocrinol. Metab. 2006 Dec;91(12):5022-8
Tan BK et al
2006/01/01
PubMed
20 Dimitriadis G et al. Insulin action in adipose tissue and muscle in hypothyroidism. J. Clin. Endocrinol. Metab. 2006 Dec;91(12):4930-7
Dimitriadis G et al
2006/01/01
PubMed
21 L坦pez-Bermejo A et al. Serum visfatin increases with progressive beta-cell deterioration. Diabetes 2006 Oct;55(10):2871-5
L坦pez-Bermejo A et al
2006/01/01
PubMed
22 Haider DG et al. The adipokine visfatin is markedly elevated in obese children. J. Pediatr. Gastroenterol. Nutr. 2006 Oct;43(4):548-9
Haider DG et al
2006/01/01
PubMed
23 Varma V et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J. Clin. Endocrinol. Metab. 2007 Feb;92(2):666-72
Varma V et al
2007/01/01
PubMed
24 Dogru T et al. Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension. J Hum Hypertens 2007 Feb;21(2):173-5
Dogru T et al
2007/01/01
PubMed
25 Manco M et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J. Clin. Endocrinol. Metab. 2007 Feb;92(2):483-90
Manco M et al
2007/01/01
PubMed
26 Yonezawa T et al. Visfatin is present in bovine mammary epithelial cells, lactating mammary gland and milk, and its expression is regulated by cAMP pathway. FEBS Lett. 2006 Dec;580(28-29):6635-43
Yonezawa T et al
2006/01/01
PubMed
27 Krzyzanowska K et al. Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity (Silver Spring) 2006 Nov;14(11):1886-9
Krzyzanowska K et al
2006/01/01
PubMed
28 Haider DG et al. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients. Clin. Pharmacol. Ther. 2007 Apr;81(4):580-5
Haider DG et al
2007/01/01
PubMed
29 Moschen AR et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J. Immunol. 2007 Feb;178(3):1748-58
Moschen AR et al
2007/01/01
PubMed
30 Ingelsson E et al. Clinical correlates of circulating visfatin levels in a community-based sample. Diabetes Care 2007 May;30(5):1278-80
Ingelsson E et al
2007/01/01
PubMed
31 Zhou H et al. Macrostemonoside A promotes visfatin expression in 3T3-L1 cells. Biol. Pharm. Bull. 2007 Feb;30(2):279-83
Zhou H et al
2007/01/01
PubMed
32 Dahl TB et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007 Feb;115(8):972-80
Dahl TB et al
2007/01/01
PubMed
33 Sun G et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am. J. Clin. Nutr. 2007 Feb;85(2):399-404
Sun G et al
2007/01/01
PubMed
34 Fern叩ndez-Real JM et al. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care 2007 Mar;30(3):616-21
Fern叩ndez-Real JM et al
2007/01/01
PubMed
35 Lewandowski KC et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007 May;50(5):1033-7
Lewandowski KC et al
2007/01/01
PubMed
36 Zhou H et al. Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells. Mol. Cell. Endocrinol. 2007 May;270(1-2):17-22
Zhou H et al
2007/01/01
PubMed
37 Takebayashi K et al. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2007 Apr;56(4):451-8
Takebayashi K et al
2007/01/01
PubMed
38 Sandeep S et al. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metab. Clin. Exp. 2007 Apr;56(4):565-70
Sandeep S et al
2007/01/01
PubMed
39 Malamitsi-Puchner A et al. Blood visfatin concentrations in normal full-term pregnancies. Acta Paediatr. 2007 Apr;96(4):526-9
Malamitsi-Puchner A et al
2007/01/01
PubMed
40 Haider DG et al. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 2007 Jul;30(7):1889-91
Haider DG et al
2007/01/01
PubMed
41 Wang P et al. The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflugers Arch. 2007 Sep;454(6):971-6
Wang P et al
2007/01/01
PubMed
42 N端sken KD et al. Preanalytical influences on the measurement of visfatin by enzyme immuno assay. Clin. Chim. Acta 2007 Jul;382(1-2):154-6
N端sken KD et al
2007/01/01
PubMed
43 Malamitsi-Puchner A et al. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007 Jun;119(6):e1314-8
Malamitsi-Puchner A et al
2007/01/01
PubMed
44 Hsieh CH et al. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2007 Aug;56(8):1087-92
Hsieh CH et al
2007/01/01
PubMed
45 Zahorska-Markiewicz B et al. Serum concentration of visfatin in obese women. Metab. Clin. Exp. 2007 Aug;56(8):1131-4
Zahorska-Markiewicz B et al
2007/01/01
PubMed
46 Oki K et al. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin. Endocrinol. (Oxf) 2007 Nov;67(5):796-800
Oki K et al
2007/01/01
PubMed
47 L坦pez-Bermejo A et al. Cord serum visfatin at term birth: maternal smoking unmasks the relation to foetal growth. Clin. Endocrinol. (Oxf) 2008 Jan;68(1):77-81
L坦pez-Bermejo A et al
2008/01/01
PubMed
48 Chen CC et al. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. Metab. Clin. Exp. 2007 Sep;56(9):1216-20
Chen CC et al
2007/01/01
PubMed
49 Brentano F et al. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum. 2007 Sep;56(9):2829-39
Brentano F et al
2007/01/01
PubMed
50 K旦rner A et al. Molecular characteristics of serum visfatin and differential detection by immunoassays. J. Clin. Endocrinol. Metab. 2007 Dec;92(12):4783-91
K旦rner A et al
2007/01/01
PubMed
51 Peng XD et al. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin. Chim. Acta 2008 Jan;387(1-2):31-5
Peng XD et al
2008/01/01
PubMed
52 Choi KM et al. Effect of exercise training on plasma visfatin and eotaxin levels. Eur. J. Endocrinol. 2007 Oct;157(4):437-42
Choi KM et al
2007/01/01
PubMed
53 Goldfine AB et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J. Clin. Endocrinol. Metab. 2007 Dec;92(12):4678-85
Goldfine AB et al
2007/01/01
PubMed
54 Seo JA et al. Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women. Diabetes Res. Clin. Pract. 2008 Jan;79(1):108-11
Seo JA et al
2008/01/01
PubMed
55 Garc鱈a-Fuentes E et al. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring) 2007 Oct;15(10):2391-5
Garc鱈a-Fuentes E et al
2007/01/01
PubMed
56 Kostapanos MS et al. Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia. Eur. J. Pharmacol. 2008 Jan;578(2-3):249-52
Kostapanos MS et al
2008/01/01
PubMed
57 Yilmaz MI et al. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol. Dial. Transplant. 2008 Mar;23(3):959-65
Yilmaz MI et al
2008/01/01
PubMed
58 Shea J et al. Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men. Am. J. Clin. Nutr. 2007 Nov;86(5):1310-5
Shea J et al
2007/01/01
PubMed
59 Rauchenzauner M et al. Adiponectin and visfatin concentrations in children treated with valproic acid. Epilepsia 2008 Feb;49(2):353-7
Rauchenzauner M et al
2008/01/01
PubMed
60 Jarrar MH et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2008 Mar;27(5):412-21
Jarrar MH et al
2008/01/01
PubMed
61 Krzysik-Walker SM et al. Is visfatin an adipokine or myokine? Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology 2008 Apr;149(4):1543-50
Krzysik-Walker SM et al
2008/01/01
PubMed
62 Filippatos TD et al. Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur. J. Clin. Invest. 2008 Jan;38(1):71-2
Filippatos TD et al
2008/01/01
PubMed
63 Yilmaz MI et al. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol. Dial. Transplant. 2008 May;23(5):1621-7
Yilmaz MI et al
2008/01/01
PubMed
64 Bouhours-Nouet N et al. High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects? Diabetes Care 2008 May;31(5):1031-6
Bouhours-Nouet N et al
2008/01/01
PubMed
65 Choi KM et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur. J. Endocrinol. 2008 Feb;158(2):203-7
Choi KM et al
2008/01/01
PubMed
66 Kendal-Wright CE et al. Chronic stretching of amniotic epithelial cells increases pre-B cell colony-enhancing factor (PBEF/visfatin) expression and protects them from apoptosis. Placenta 2008 Mar;29(3):255-65
Kendal-Wright CE et al
2008/01/01
PubMed
67 Ib叩単ez L et al. Visceral adiposity without overweight in children born small for gestational age. J. Clin. Endocrinol. Metab. 2008 Jun;93(6):2079-83
Ib叩単ez L et al
2008/01/01
PubMed
68 Palin MF et al. Visfatin expression is not associated with adipose tissue abundance in the porcine model. Domest. Anim. Endocrinol. 2008 Jul;35(1):58-73
Palin MF et al
2008/01/01
PubMed
69 de Luis DA et al. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients. Nutrition 2008 Jun;24(6):517-21
de Luis DA et al
2008/01/01
PubMed
70 Matsui H et al. Visfatin (pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2008 Apr;67(4):571-2
Matsui H et al
2008/01/01
PubMed
71 Botella-Carretero JI et al. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg 2008 Aug;18(8):1000-6
Botella-Carretero JI et al
2008/01/01
PubMed
72 Zhong M et al. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clin. Endocrinol. (Oxf) 2008 Dec;69(6):878-84
Zhong M et al
2008/01/01
PubMed
73 Retnakaran R et al. Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study. Clin. Endocrinol. (Oxf) 2008 Dec;69(6):885-93
Retnakaran R et al
2008/01/01
PubMed
74 Ib叩単ez L et al. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. J. Clin. Endocrinol. Metab. 2008 Jul;93(7):2774-8
Ib叩単ez L et al
2008/01/01
PubMed
75 Brema I et al. Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab 2008 Jul;10(7):600-2
Brema I et al
2008/01/01
PubMed
76 Perez-Iglesias R et al. Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment. J Clin Psychopharmacol 2008 Jun;28(3):289-95
Perez-Iglesias R et al
2008/01/01
PubMed
77 Younossi ZM et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 2008 Nov;18(11):1430-7
Younossi ZM et al
2008/01/01
PubMed
78 Mazaki-Tovi S et al. Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturiti
Mazaki-Tovi S et al
2008/01/01
PubMed
79 Kato A et al. Relationship between serum pre-B cell colony-enhancing factor/visfatin and atherosclerotic parameters in chronic hemodialysis patients. Am. J. Nephrol. 2009;29(1):31-5
Kato A et al
2009/01/01
PubMed
80 Dahmen N et al. Elevated peripheral visfatin levels in narcoleptic patients. PLoS ONE 2008;3(8):e2980
Dahmen N et al
2008/01/01
PubMed
81 Panidis D et al. Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Eur. J. Intern. Med. 2008 Oct;19(6):406-12
Panidis D et al
2008/01/01
PubMed
82 Wang P et al. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc. Res. 2009 Feb;81(2):370-80
Wang P et al
2009/01/01
PubMed
83 Storka A et al. Angiotensin inhibition stimulates PPARgamma and the release of visfatin. Eur. J. Clin. Invest. 2008 Nov;38(11):820-6
Storka A et al
2008/01/01
PubMed
84 Li L et al. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine 2009 Jan;45(1):12-9
Li L et al
2009/01/01
PubMed
85 de Boer JF et al. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009 Feb;296(2):G196-201
de Boer JF et al
2009/01/01
PubMed
86 de Luis DA et al. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose. Nutrition 2009 Jan;
de Luis DA et al
2009/01/01
PubMed
87 Skokowa J et al. NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. Nat. Med. 2009 Feb;15(2):151-8
Skokowa J et al
2009/01/01
PubMed
  • No.: 1
  • 文献情報:
    Chan DC et al. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin. Chem. 2005 Mar;51(3):578-85
    Chan DC et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Berndt J et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005 Oct;54(10):2911-6
    Berndt J et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Chen MP et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2006 Jan;91(1):295-9
    Chen MP et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Hammarstedt A et al. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J. Clin. Endocrinol. Metab. 2006 Mar;91(3):1181-4
    Hammarstedt A et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Otero M et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2006 Sep;65(9):1198-201
    Otero M et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Haider DG et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J. Clin. Endocrinol. Metab. 2006 Apr;91(4):1578-81
    Haider DG et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Krzyzanowska K et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin. Sci. 2006 May;110(5):605-9
    Krzyzanowska K et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Curat CA et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006 Apr;49(4):744-7
    Curat CA et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    B旦ttcher Y et al. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J. Clin. Endocrinol. Metab. 2006 Jul;91(7):2725-31
    B旦ttcher Y et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Pagano C et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J. Clin. Endocrinol. Metab. 2006 Aug;91(8):3165-70
    Pagano C et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Haider DG et al. Free fatty acids normalize a rosiglitazone-induced visfatin release. Am. J. Physiol. Endocrinol. Metab. 2006 Nov;291(5):E885-90
    Haider DG et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Haider DG et al. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006 Aug;49(8):1909-14
    Haider DG et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Nowell MA et al. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 2006 Jul;54(7):2084-95
    Nowell MA et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Frydelund-Larsen L et al. Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise. Am. J. Physiol. Endocrinol. Metab. 2007 Jan;292(1):E24-31
    Frydelund-Larsen L et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Haider DG et al. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4702-4
    Haider DG et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Schindler K et al. Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects. Eur. J. Clin. Invest. 2006 Sep;36(9):640-6
    Schindler K et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Jian WX et al. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabet. Med. 2006 Sep;23(9):967-73
    Jian WX et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Dogru T et al. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res. Clin. Pract. 2007 Apr;76(1):24-9
    Dogru T et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Tan BK et al. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. J. Clin. Endocrinol. Metab. 2006 Dec;91(12):5022-8
    Tan BK et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Dimitriadis G et al. Insulin action in adipose tissue and muscle in hypothyroidism. J. Clin. Endocrinol. Metab. 2006 Dec;91(12):4930-7
    Dimitriadis G et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    L坦pez-Bermejo A et al. Serum visfatin increases with progressive beta-cell deterioration. Diabetes 2006 Oct;55(10):2871-5
    L坦pez-Bermejo A et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Haider DG et al. The adipokine visfatin is markedly elevated in obese children. J. Pediatr. Gastroenterol. Nutr. 2006 Oct;43(4):548-9
    Haider DG et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Varma V et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J. Clin. Endocrinol. Metab. 2007 Feb;92(2):666-72
    Varma V et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Dogru T et al. Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension. J Hum Hypertens 2007 Feb;21(2):173-5
    Dogru T et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Manco M et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J. Clin. Endocrinol. Metab. 2007 Feb;92(2):483-90
    Manco M et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Yonezawa T et al. Visfatin is present in bovine mammary epithelial cells, lactating mammary gland and milk, and its expression is regulated by cAMP pathway. FEBS Lett. 2006 Dec;580(28-29):6635-43
    Yonezawa T et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Krzyzanowska K et al. Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity (Silver Spring) 2006 Nov;14(11):1886-9
    Krzyzanowska K et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Haider DG et al. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients. Clin. Pharmacol. Ther. 2007 Apr;81(4):580-5
    Haider DG et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Moschen AR et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J. Immunol. 2007 Feb;178(3):1748-58
    Moschen AR et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Ingelsson E et al. Clinical correlates of circulating visfatin levels in a community-based sample. Diabetes Care 2007 May;30(5):1278-80
    Ingelsson E et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Zhou H et al. Macrostemonoside A promotes visfatin expression in 3T3-L1 cells. Biol. Pharm. Bull. 2007 Feb;30(2):279-83
    Zhou H et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Dahl TB et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007 Feb;115(8):972-80
    Dahl TB et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Sun G et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am. J. Clin. Nutr. 2007 Feb;85(2):399-404
    Sun G et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Fern叩ndez-Real JM et al. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care 2007 Mar;30(3):616-21
    Fern叩ndez-Real JM et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Lewandowski KC et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007 May;50(5):1033-7
    Lewandowski KC et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Zhou H et al. Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells. Mol. Cell. Endocrinol. 2007 May;270(1-2):17-22
    Zhou H et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Takebayashi K et al. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2007 Apr;56(4):451-8
    Takebayashi K et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Sandeep S et al. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metab. Clin. Exp. 2007 Apr;56(4):565-70
    Sandeep S et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Malamitsi-Puchner A et al. Blood visfatin concentrations in normal full-term pregnancies. Acta Paediatr. 2007 Apr;96(4):526-9
    Malamitsi-Puchner A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Haider DG et al. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 2007 Jul;30(7):1889-91
    Haider DG et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Wang P et al. The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflugers Arch. 2007 Sep;454(6):971-6
    Wang P et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    N端sken KD et al. Preanalytical influences on the measurement of visfatin by enzyme immuno assay. Clin. Chim. Acta 2007 Jul;382(1-2):154-6
    N端sken KD et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Malamitsi-Puchner A et al. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007 Jun;119(6):e1314-8
    Malamitsi-Puchner A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Hsieh CH et al. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2007 Aug;56(8):1087-92
    Hsieh CH et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Zahorska-Markiewicz B et al. Serum concentration of visfatin in obese women. Metab. Clin. Exp. 2007 Aug;56(8):1131-4
    Zahorska-Markiewicz B et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Oki K et al. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin. Endocrinol. (Oxf) 2007 Nov;67(5):796-800
    Oki K et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    L坦pez-Bermejo A et al. Cord serum visfatin at term birth: maternal smoking unmasks the relation to foetal growth. Clin. Endocrinol. (Oxf) 2008 Jan;68(1):77-81
    L坦pez-Bermejo A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Chen CC et al. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. Metab. Clin. Exp. 2007 Sep;56(9):1216-20
    Chen CC et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Brentano F et al. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum. 2007 Sep;56(9):2829-39
    Brentano F et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    K旦rner A et al. Molecular characteristics of serum visfatin and differential detection by immunoassays. J. Clin. Endocrinol. Metab. 2007 Dec;92(12):4783-91
    K旦rner A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Peng XD et al. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin. Chim. Acta 2008 Jan;387(1-2):31-5
    Peng XD et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Choi KM et al. Effect of exercise training on plasma visfatin and eotaxin levels. Eur. J. Endocrinol. 2007 Oct;157(4):437-42
    Choi KM et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Goldfine AB et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J. Clin. Endocrinol. Metab. 2007 Dec;92(12):4678-85
    Goldfine AB et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Seo JA et al. Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women. Diabetes Res. Clin. Pract. 2008 Jan;79(1):108-11
    Seo JA et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Garc鱈a-Fuentes E et al. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring) 2007 Oct;15(10):2391-5
    Garc鱈a-Fuentes E et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Kostapanos MS et al. Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia. Eur. J. Pharmacol. 2008 Jan;578(2-3):249-52
    Kostapanos MS et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Yilmaz MI et al. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol. Dial. Transplant. 2008 Mar;23(3):959-65
    Yilmaz MI et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Shea J et al. Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men. Am. J. Clin. Nutr. 2007 Nov;86(5):1310-5
    Shea J et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Rauchenzauner M et al. Adiponectin and visfatin concentrations in children treated with valproic acid. Epilepsia 2008 Feb;49(2):353-7
    Rauchenzauner M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Jarrar MH et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2008 Mar;27(5):412-21
    Jarrar MH et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Krzysik-Walker SM et al. Is visfatin an adipokine or myokine? Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology 2008 Apr;149(4):1543-50
    Krzysik-Walker SM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Filippatos TD et al. Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur. J. Clin. Invest. 2008 Jan;38(1):71-2
    Filippatos TD et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Yilmaz MI et al. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol. Dial. Transplant. 2008 May;23(5):1621-7
    Yilmaz MI et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Bouhours-Nouet N et al. High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects? Diabetes Care 2008 May;31(5):1031-6
    Bouhours-Nouet N et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Choi KM et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur. J. Endocrinol. 2008 Feb;158(2):203-7
    Choi KM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Kendal-Wright CE et al. Chronic stretching of amniotic epithelial cells increases pre-B cell colony-enhancing factor (PBEF/visfatin) expression and protects them from apoptosis. Placenta 2008 Mar;29(3):255-65
    Kendal-Wright CE et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Ib叩単ez L et al. Visceral adiposity without overweight in children born small for gestational age. J. Clin. Endocrinol. Metab. 2008 Jun;93(6):2079-83
    Ib叩単ez L et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Palin MF et al. Visfatin expression is not associated with adipose tissue abundance in the porcine model. Domest. Anim. Endocrinol. 2008 Jul;35(1):58-73
    Palin MF et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    de Luis DA et al. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients. Nutrition 2008 Jun;24(6):517-21
    de Luis DA et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Matsui H et al. Visfatin (pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2008 Apr;67(4):571-2
    Matsui H et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Botella-Carretero JI et al. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg 2008 Aug;18(8):1000-6
    Botella-Carretero JI et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Zhong M et al. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clin. Endocrinol. (Oxf) 2008 Dec;69(6):878-84
    Zhong M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Retnakaran R et al. Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study. Clin. Endocrinol. (Oxf) 2008 Dec;69(6):885-93
    Retnakaran R et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Ib叩単ez L et al. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. J. Clin. Endocrinol. Metab. 2008 Jul;93(7):2774-8
    Ib叩単ez L et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Brema I et al. Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab 2008 Jul;10(7):600-2
    Brema I et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Perez-Iglesias R et al. Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment. J Clin Psychopharmacol 2008 Jun;28(3):289-95
    Perez-Iglesias R et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Younossi ZM et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 2008 Nov;18(11):1430-7
    Younossi ZM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Mazaki-Tovi S et al. Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturiti
    Mazaki-Tovi S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Kato A et al. Relationship between serum pre-B cell colony-enhancing factor/visfatin and atherosclerotic parameters in chronic hemodialysis patients. Am. J. Nephrol. 2009;29(1):31-5
    Kato A et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Dahmen N et al. Elevated peripheral visfatin levels in narcoleptic patients. PLoS ONE 2008;3(8):e2980
    Dahmen N et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Panidis D et al. Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Eur. J. Intern. Med. 2008 Oct;19(6):406-12
    Panidis D et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Wang P et al. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc. Res. 2009 Feb;81(2):370-80
    Wang P et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Storka A et al. Angiotensin inhibition stimulates PPARgamma and the release of visfatin. Eur. J. Clin. Invest. 2008 Nov;38(11):820-6
    Storka A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Li L et al. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine 2009 Jan;45(1):12-9
    Li L et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    de Boer JF et al. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009 Feb;296(2):G196-201
    de Boer JF et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    de Luis DA et al. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose. Nutrition 2009 Jan;
    de Luis DA et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Skokowa J et al. NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. Nat. Med. 2009 Feb;15(2):151-8
    Skokowa J et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed